TY  - CONF

T1  - 857P - Baseline fracture risk in men with prostate cancer starting the STAMPEDE trial

JO  - Annals of Oncology

PY  - 2020/01/08

AU  - Brown JE

AU  - Handforth C

AU  - Walsh J

AU  - Pezaro C

AU  - Sydes MR

AU  - Clarke NW

AU  - James ND

AU  - McCloskey E

ED  - 

DO  - DOI: 10.1093/annonc/mdz248.014

PB  - Elsevier BV

VL  - 30

IS  - Suppl 5

SP  - v334

EP  - v335

Y2  - 2024/09/19

ER  -